{"id":3488,"date":"2025-09-05T17:01:04","date_gmt":"2025-09-05T08:01:04","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/member_search\/3488"},"modified":"2025-09-05T17:01:04","modified_gmt":"2025-09-05T08:01:04","slug":"%e5%b0%8f%e5%b1%b1%e3%80%80%e9%9a%86%e6%96%87","status":"publish","type":"researcher","link":"https:\/\/atlas.ncc.go.jp\/en\/member_search\/3488","title":{"rendered":"Takafumi Koyama EN"},"template":"","class_list":["post-3488","researcher","type-researcher","status-publish","hentry","en-US"],"acf":{"name_eg":"Takafumi Koyama","familyName_eg":"Koyama","has_jp_name":true,"name_jp":"\u5c0f\u5c71\u3000\u9686\u6587","researcher_photo":1952,"participated_in":["-1"],"degree":"MD, PhD","position":"Head of Physician","eg_position":"Head of Physician","facilities":3399,"department":["35"],"speciality":"Early drug development","eg_speciality":"Early drug development","background":"<h2><strong>Dr. KOYAMA's Story<\/strong><\/h2>\r\n<p>Dr. Koyama graduated from Kanazawa University School of Medicine in 2006. After completing the residency at Kishiwada Tokusyukai Hospital and the fellowship of hematology and oncology at Kameda General Hospital, he joined the department of medical oncology at Kameda General Hospital as an attending physician in 2012. In 2016, he joined the department of experimental therapeutics at National Cancer Center Hospital as a fellow in 2016. In 2018, after completing the training in early drug development and translational research, he became an attending physician of the department of experimental therapeutics at National Cancer Center Hospital. Current position from April 2022. He is primarily involved in early drug development and TR.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>Traslational research, Precision oncology<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 66px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">Apr\/2022-Present<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Head of Physician, Department of Experimental Therapeutics, National Cancer Center Hospital<\/td>\r\n<\/tr>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 12px;\">Apr\/2018-Mar\/2022<\/td>\r\n<td style=\"width: 77.5977%; height: 12px;\">Attending Physician, Department of Experimental Therapeutics, National Cancer Center Hospital<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 24px;\">Apr\/2016-Mar\/2016<\/td>\r\n<td style=\"width: 77.5977%; height: 24px;\">Fellow, Department of Experimental Therapeutics, National Cancer Center Hospital<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">Apr\/2011-Mar\/2016<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Attending Physician, Department of Medical Oncology, Kameda Medical Center<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">Apr\/2008-Mar\/2011<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Fellow, Department of Medical Oncology, Kameda Medical Center<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Specialized field<\/h2>\r\n<p>Medical Oncology, Heamatology<\/p>\r\n<h2>Qualifications, certified physicians, medical specialists<\/h2>\r\n<p>Board Certified Medical Oncology, Japanese Society of Medical Oncology<br \/>\r\nBoard Certified Haematologist of Japanese Society of Haematology<br \/>\r\nBoard Certified Member of the Japanese Society of Internal Medicine<\/p>","eg_background":"<h2><strong>Dr. KOYAMA's Story<\/strong><\/h2>\r\n<p>Dr. Koyama graduated from Kanazawa University School of Medicine in 2006. After completing the residency at Kishiwada Tokusyukai Hospital and the fellowship of hematology and oncology at Kameda General Hospital, he joined the department of medical oncology at Kameda General Hospital as an attending physician in 2012. In 2016, he joined the department of experimental therapeutics at National Cancer Center Hospital as a fellow in 2016. In 2018, after completing the training in early drug development and translational research, he became an attending physician of the department of experimental therapeutics at National Cancer Center Hospital. Current position from April 2022. He is primarily involved in early drug development and TR.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>Traslational research, Precision oncology<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 66px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">Apr\/2022-Present<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Head of Physician, Department of Experimental Therapeutics, National Cancer Center Hospital<\/td>\r\n<\/tr>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 12px;\">Apr\/2018-Mar\/2022<\/td>\r\n<td style=\"width: 77.5977%; height: 12px;\">Attending Physician, Department of Experimental Therapeutics, National Cancer Center Hospital<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 24px;\">Apr\/2016-Mar\/2016<\/td>\r\n<td style=\"width: 77.5977%; height: 24px;\">Fellow, Department of Experimental Therapeutics, National Cancer Center Hospital<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">Apr\/2011-Mar\/2016<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Attending Physician, Department of Medical Oncology, Kameda Medical Center<\/td>\r\n<\/tr>\r\n<tr style=\"height: 24px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">Apr\/2008-Mar\/2011<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">Fellow, Department of Medical Oncology, Kameda Medical Center<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Specialized field<\/h2>\r\n<p>Medical Oncology, Heamatology<\/p>\r\n<h2>Qualifications, certified physicians, medical specialists<\/h2>\r\n<p>Board Certified Medical Oncology, Japanese Society of Medical Oncology<br \/>\r\nBoard Certified Haematologist of Japanese Society of Haematology<br \/>\r\nBoard Certified Member of the Japanese Society of Internal Medicine<\/p>","researcher_outerlink1":"https:\/\/phase1-oncol.ncc.go.jp\/","researcher_outerlink2":"","researcher_outerlink3":"","researcher_outerlink4":"","researcher_outerlink5":"","is_retired":false},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher\/3488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/researcher"}],"acf:post":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/facility\/3399"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}